×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CING – cingulate inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CING
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/3
08:00 am
cing
Cingulate Completes Pre-NDA Meeting with FDA to Discuss New Drug Application for lead ADHD Asset CTx-1301
Low
Report
Cingulate Completes Pre-NDA Meeting with FDA to Discuss New Drug Application for lead ADHD Asset CTx-1301
3/26
05:00 pm
cing
Cingulate Inc. Reports Full Year 2024, Fourth Quarter Results, and Provides Development Update on Major Milestones Achieved
Medium
Report
Cingulate Inc. Reports Full Year 2024, Fourth Quarter Results, and Provides Development Update on Major Milestones Achieved
3/6
08:12 am
cing
Cingulate Inc. (NASDAQ: CING) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Low
Report
Cingulate Inc. (NASDAQ: CING) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
3/4
09:08 am
cing
Cingulate Reports Safety Results from Final Phase 3 Trials for Lead ADHD Asset CTx-1301: On Track to File for FDA Approval Mid-2025 [Yahoo! Finance]
Medium
Report
Cingulate Reports Safety Results from Final Phase 3 Trials for Lead ADHD Asset CTx-1301: On Track to File for FDA Approval Mid-2025 [Yahoo! Finance]
3/4
09:00 am
cing
Cingulate Reports Safety Results from Final Phase 3 Trials for Lead ADHD Asset CTx-1301: On Track to File for FDA Approval Mid-2025
High
Report
Cingulate Reports Safety Results from Final Phase 3 Trials for Lead ADHD Asset CTx-1301: On Track to File for FDA Approval Mid-2025
1/30
08:18 am
cing
Cingulate Inc. (NASDAQ: CING) had its price target raised by analysts at HC Wainwright from $8.00 to $20.00. They now have a "buy" rating on the stock.
Medium
Report
Cingulate Inc. (NASDAQ: CING) had its price target raised by analysts at HC Wainwright from $8.00 to $20.00. They now have a "buy" rating on the stock.
1/11
05:37 am
cing
Cingulate Inc. (NASDAQ: CING) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Neutral
Report
Cingulate Inc. (NASDAQ: CING) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
1/10
08:03 am
cing
Cingulate Inc. (NASDAQ: CING) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $12.00 price target on the stock.
High
Report
Cingulate Inc. (NASDAQ: CING) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $12.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
3/27
05:13 pm
cing
Form 10-K Cingulate Inc. For: Dec 31
Low
Report
Form 10-K Cingulate Inc. For: Dec 31
3/26
09:06 am
cing
Form 8-K Cingulate Inc. For: Mar 26
Medium
Report
Form 8-K Cingulate Inc. For: Mar 26
3/4
09:06 am
cing
Form 8-K Cingulate Inc. For: Mar 04
Low
Report
Form 8-K Cingulate Inc. For: Mar 04
2/20
06:00 pm
cing
Form 4 Cingulate Inc. For: Feb 18 Filed by: Silva Raul R.
Medium
Report
Form 4 Cingulate Inc. For: Feb 18 Filed by: Silva Raul R.
2/20
06:00 pm
cing
Form 4 Cingulate Inc. For: Feb 18 Filed by: Callahan Jennifer L.
Medium
Report
Form 4 Cingulate Inc. For: Feb 18 Filed by: Callahan Jennifer L.
2/20
06:00 pm
cing
Form 4 Cingulate Inc. For: Feb 18 Filed by: Brams Matthew
Medium
Report
Form 4 Cingulate Inc. For: Feb 18 Filed by: Brams Matthew
2/20
06:00 pm
cing
Form 4 Cingulate Inc. For: Feb 18 Filed by: Myers Laurie
Medium
Report
Form 4 Cingulate Inc. For: Feb 18 Filed by: Myers Laurie
2/20
06:00 pm
cing
Form 4 Cingulate Inc. For: Feb 18 Filed by: Schaffer Shane J.
Medium
Report
Form 4 Cingulate Inc. For: Feb 18 Filed by: Schaffer Shane J.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: